$AUPH

Aurinia Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$16.25 β–Ό-9.872%

Last Close

VOLUME

5,505,141

DAY RANGE

18 - 19.22

52 WEEK

9.72 - 33.97

Join Discuss about AUPH with like-minded investors

profile
@HeyShoe #droscrew
recently

RECAP 1/13 Chatter: $TKAT - China NFT $EZPQ CEO resigns $QS + moving beyond EVs $DNB - FTC $XLNX $AMD + SAMR $AUPH $AMLX $BHVN + $BIIB $PFE $BNTX $MRNA - SCOTUS Biden Vaccine ruling

73 Replies 11 πŸ‘ 12 πŸ”₯

profile
@dros #droscrew
recently

Unusually active option classes on open December 3rd $APSG $SU $BIG $UCO $ARDX $USO $UPST $DNA $JD $AUPH

89 Replies 14 πŸ‘ 15 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$AUPH jump any moment....ask side Apr is avove 5.00

71 Replies 10 πŸ‘ 7 πŸ”₯

profile
@Pal #droscrew
recently

Wish I followed. Too deep in $AUPH

95 Replies 15 πŸ‘ 12 πŸ”₯

profile
@bunnytoad69 #droscrew
recently

ATVI - position sizing should probably reflect risk not confidence (lol) ENPH - "BT69 PLAYED HIMSELF .. got em" rebounded significantly ($120 -> $237) AUPH - "BT69 PLAYED HIMSELF .. got em". got some nice biglyness ($10 -> $30) most of the losers are short term risk (options), oversized positions gone wrong, or both!

107 Replies 10 πŸ‘ 8 πŸ”₯

profile
@netxpert #marketassasins
recently

for the very first time in a long time my entire portfolio is on fire except CLOV NVDA Apple TSLA AQST AUPH LCID SAVA

127 Replies 7 πŸ‘ 7 πŸ”₯

profile
@netxpert #marketassasins
recently

@marketjay hope you having a relaxing weekend. Last week overall very green couple of my key holdings LCID and AUPH went ballistic alongside NVDA. Disappointed with Apple but glad Apple did hold strong steady support around 147.00. Question I have is on $ATER earnings November 8th Short Interest increased and as of last update at 43.00% 99% utilization. Whats your read on $ATER ?

90 Replies 11 πŸ‘ 11 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$AUPH 35C Dec

46 Replies 13 πŸ‘ 8 πŸ”₯

profile
@netxpert #marketassasins
recently

except $AUPH all others are sympathy play. I agree price volume will be the key to what moves tomorrow. I am also keeping an eye on BBIG. Friday AH movement suggest late news catalyst pushed the price.

69 Replies 12 πŸ‘ 15 πŸ”₯

profile
@netxpert #marketassasins
recently

What do you all think is big mover tomorrow? DWAC, PHUN, MARK, AUPH, BENE?

116 Replies 11 πŸ‘ 12 πŸ”₯

profile
@HeyShoe #droscrew
recently

RECAP 10/22 Chatter: $BENE, $MARK, $ZGYH, $IZEA, $SGBX + WTF runners.... $AUPH + BMY approach

97 Replies 11 πŸ‘ 6 πŸ”₯

profile
@HeyShoe #droscrew
recently

$FB - Second Whistle blower $MRNA - No FDA stance on Booster $AUPH + Betaville Takeover Chatter $RRD + Unsolicited proposal $WRAP + new product $BABA + Jack Ma out of view

41 Replies 9 πŸ‘ 8 πŸ”₯

profile
@Pal #droscrew
recently

$AUPH doing great work today

63 Replies 7 πŸ‘ 14 πŸ”₯

profile
@Pal #droscrew
recently

Seems like lots of the fake news releases lately---had a buyout announcement for $AUPH a few weeks ago with price and other typical merger announcement language.

79 Replies 7 πŸ‘ 6 πŸ”₯

profile
@marketjay #marketassasins
recently

not familiar with AUPH

93 Replies 6 πŸ‘ 9 πŸ”₯

profile
@netxpert #marketassasins
recently

Agree I guess I will just hold. It's really looking like it will be one of the fastest retrace back to pre split levels. Super Green Day for my core holdings of NVDA NARA AUPH but Apple is lagging.

142 Replies 6 πŸ‘ 9 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$AUPH strangle 15/12 Jun

79 Replies 11 πŸ‘ 12 πŸ”₯

profile
@bunnytoad69 #droscrew
recently

Today I bought: CBAY, BFLY, AUPH, CRON, NNDM

108 Replies 15 πŸ‘ 12 πŸ”₯

profile
@Navneet #droscrew
recently

did you see $auph flow

74 Replies 6 πŸ‘ 11 πŸ”₯

Key Metrics

Market Cap

2.31 B

Beta

1.17

Avg. Volume

2.59 M

Shares Outstanding

128.40 M

Yield

0%

Public Float

0

Next Earnings Date

2022-02-23

Next Dividend Date

Company Information

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.

CEO: Peter Greenleaf

Website:

HQ: 1203-4464 Markham St Victoria, V8Z 7X8 British Columbia

Related News